A primer of disopyramide treatment of obstructive hypertrophic cardiomyopathy |
| |
| Authors: | Sherrid Mark V Arabadjian Milla |
| |
| Affiliation: | Division of Cardiology, St. Luke's-Roosevelt Hospital Center, New York, NY 10019, USA. msherrid@chpnet.org |
| |
| Abstract: | Hypertrophic cardiomyopathy (HCM) occurs in 1 in 500 individuals. Treatment options for HCM differ from those administered in coronary disease, heart failure, and valvular disease patients that comprise the core of many cardiology practices. In this article, we offer a concise summary of the therapeutic use of disopyramide for reducing gradients and relieving symptoms in obstructive HCM. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
